Clinical Trial: TNFAIP3 Gene Expression in Ankylosing Spondylitis and Psoriatic Arthritis Patients and Its Relation to Disease Activity

U.S., April 3 -- ClinicalTrials.gov registry received information related to the study (NCT07507487) titled 'TNFAIP3 Gene Expression in Ankylosing Spondylitis and Psoriatic Arthritis Patients and Its Relation to Disease Activity' on March 16.

Brief Summary: 1. Identify gene expression of TNFAIP3 in ankylosing spondylitis and psoriatic arthritis patients.

2. Detect relation between TNFAIP3 and disease activity.

Inclusion criteria:

1. Patients diagnosed with ankylosing spondylitis according to Modified New York classification criteria 1984 (10).

2. Patients diagnosed with psoriatic arthritis (PsA patients (age >=18 years) who fulfilled the CASPAR classification criteria for PsA 2010) (11).

b. Exclusion criteria: Patients with erythroder...